Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis

Summary

The purpose of this research study is to evaluate the safety, tolerability, and efficacy of Interferon gamma-1b (IFN-gamma 1b) when administered by subcutaneous injection over a period of 4 weeks to patients with mild-to-moderate cystic fibrosis. Additionally, preliminary assessments on the effects of IFN-gamma 1b on lung function and other indicators of health will be made.

Timeline

Start

2002-04

Primary completion

—

Completion

2003-03

Drugs

Indications